Musculoskeletal Abnormalities
12
4
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (12)
GLP-1R Actions on Muscle and the Skeleton
Mind-Body Conditioning Course for University Dance Students
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities
Effects of Emicizumab Treatment in Patients With Hemophilia A
Prospective Evaluation Assessing U2 MB™ Total Knee System
Evaluation of Non-Surgical and Arthroscopic Treatment for Hip Microinstability
RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration
Pediatric Radio Frequency Coils Generic
Musculoskeletal Symptoms in Post Acute Covid-19 Patients
Exercise Program Based on Motor Learning and Forward Head Posture Correction
Improving Informed Consent for Cleft Palate Repair
Cross-Disciplinary Workplace Intervention Strategy for Chronic Musculoskeletal Disorders